Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
about
Coffee intake in midlife and risk of dementia and its neuropathologic correlates.Coffee, but not caffeine, has positive effects on cognition and psychomotor behavior in aging.Health benefits of methylxanthines in neurodegenerative diseases.Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.
P2860
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@en
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@nl
type
label
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@en
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@nl
prefLabel
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@en
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@nl
P356
P1476
Putative neuroprotective effects of caffeine in clinical trials. Concluding remarks.
@en
P2093
Rodrigo A Cunha
P304
P356
10.3233/JAD-2010-01411
P478
20 Suppl 1
P577
2010-01-01T00:00:00Z